Rare driver mutations in advanced, oncogene-addicted non-small cell lung cancer: a north italian, real-world, registry experience

HIGHLIGHTS

• What: The authors focused on the clinical characterization and outcomes of with rare molecular alterations: EGFR exon 20 insertion non-activating EGFR mutations BRAF V600E and non-V600 ROS1 and RET rearrangements MET ErbB2 and FGFR mutations. The authors focus on the rarest molecular subpopulations among the mandatory ten, describing their clinical features and outcomes according to the therapies approved in Italy for each subtype following the initial diagnosis. The authors describe the patients the rarest moThe data fro . the whole oncogene-addicted population of the with NEROnE study, a lecular, driver alterationsdata among the pivotal analysed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.